Fig. 1From: Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitisReduced levels of inflammatory cytokines and NO after stimulation of astroglial cells in vitro. Primary neonatal rat astroglial cells were either stimulated with LPS, heat-inactivated (HI P21), or living S. pneumoniae serotype 3 (Living P21) in the presence or absence of metformin. Metformin significantly reduced levels of IL-1β (p = 0.0109 in LPS- and p = 0.0004 in HI P21 stimulated cells, a). IL-6 (p = 0.0050 in LPS-, p = 0.0003 in HI P21- and p = 0.0229 in living P21-stimulated cells, b) and nitric oxide (p = 0.0024 in LPS-, p = 0.0003 in HIP21- and p=0.0005 in living P21-stimualted cells, f) levels were significantly reduced by metformin independent of stimulating agents. IL-10 (p = 0.0015, c) and TNF-α (p < 0.0001, d) levels were significantly reduced in astroglial cells stimulated by HI P21 in the presence of metformin. No effect of metformin treatment on IFN-γ levels (e) was foundBack to article page